Article PDF
References
Berk BC, Fujiwara K, Lehoux S : ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117: 568–575.
Iwanaga Y, Aoyama T, Kihara Y, et al: Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. J Am Coll Cardiol 2002; 39: 1384–1391.
Mujumdar VS, Smiley LM, Tyagi SC : Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Int J Cardiol 2001; 79: 277–286.
Matsusaka H, Ide T, Matsushima S, et al: Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload. Hypertension 2006; 47: 711–717.
Heymans S, Lupu F, Terclavers S, et al: Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. Am J Pathol 2005; 166: 15–25.
Lin J, Davis HB, Dai Q, et al: Effects of early and late chronic pressure overload on extracellular matrix remodeling. Hypertens Res 2008; 31: 1225–1231.
Hinojosa-Laborde C, Craig T, Zheng W, et al: Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension 2004; 44: 405–409.
Ahmed SH, Clark LL, Pennington WR, et al: Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006; 113: 2089–2096.
Ishikawa J, Kario K, Matsui Y, et al: Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy. Hypertens Res 2005; 28: 995–1001.
Chapman RE, Spinale FG : Extracellular protease activation and unraveling of the myocardial interstitium: critical steps toward clinical applications. Am J Physiol Heart Circ Physiol 2004; 286: H1–H10.
Hudson MP, Armstrong PW, Ruzyllo W, et al: Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. J Am Coll Cardiol 2006; 48: 15–20.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ito, T. Matrix Metalloproteinases in Hypertensive Heart Disease: New Mechanistic Insights. Hypertens Res 31, 1061–1062 (2008). https://doi.org/10.1291/hypres.31.1061
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1061